Cdk/Crk Inhibitor,1-(2,6-dichlorophenyl)-6-[[4-(2-hydroxyethoxy)phenyl]methyl]-3-propan-2-yl-2H-pyrazolo[3,4-d]pyrimidin-4-one,784211-09-2

公告提醒：爱必信所有产品和服务仅用于科学研究，不用于临床应用及其他用途提供产品和服务（也不为任何个人提供产品和服务）!

试剂描述：

产品名称：Cdk/Crk Inhibitor

产品别名：1-(2,6-dichlorophenyl)-6-[[4-(2-hydroxyethoxy)phenyl]methyl]-3-propan-2-yl-2H-pyrazolo[3,4-d]pyrimidin-4-one

CAS号：784211-09-2

英文别名：1-(2,6-dichlorophenyl)-6-[[4-(2-hydroxyethoxy)phenyl]methyl]-3-propan-2-yl-2H-pyrazolo[3,4-d]pyrimidin-4-one

分子量：473.4

分子式：C₂₃H₂₂Cl₂N₄O₃

纯度：>95%

外观：见爱必信官网

保存方法：Store at -20° C

描述：Cdk/Crk Inhibitor is a cell-permeable pyrazolo-pyrimidinone compound that acts as a potent, selective, and ATP-competitive inhibitor of Cdks (IC₅₀ = 48 nM, 15 nM, 9 nM, 10 nM, 71 nM, and 9 nM for Cdc2 (Cdk1)/cyclin B, Cdk2/cyclin E, Cdk3/cyclin E, Cdk5/p35, Cdk7/cyclin H/MAT1, and Cdk9, respectively). It inhibits Cdk4/cyclin D1, Cdk6/cyclin D3, and GSK-3β only at much higher concentrations (IC₅₀ = 839 nM, 282 nM, and 754 nM, respectively) and exhibits little activity towards a panel of 60 other kinases. Cdk/Crk Inhibitor is a broad-spectrum growth inhibitor toward tumor cells, but not non-transformed quiescent fibroblasts.

应用：A pyrazolo-pyrimidinone compound that acts as a potent, selective & ATP-competitive inhibitor of Cdks

产品信息订购：

产品更多信息请进入爱必信网站咨询